Kevin Huhn

Louisiana university’s medical cannabis partner undergoing ownership feud

Southern University in Louisiana has contracted with a company to run the school’s medical marijuana program, but the firm’s principals are embroiled in an ownership struggle. According to The Advocate, the Baton Rouge university said Thursday it had signed a contract with the two majority owners of Advanced Biomedics. Southern picked the company last fall […]

Read More

Minnesota medical marijuana company LeafLine loses CEO

The chief executive of one of Minnesota’s two medical marijuana manufacturers has left the company after years of financial losses.

Andrew Bachman, LeafLine Labs’ co-founder and its chief executive since 2016, is no longer with the company “in any official capacity,” the company said Thursday in a statement to the Associated Press.

Read More

Marijuana cultivators find ways to shorten curing process

In an ideal world, cultivators would have the luxury of time when it comes to drying and curing their cannabis.

They’d take 30-60 days – waiting, sniffing, eyeing and “burping” – to achieve the ideal cannabinoid and terpene profile for each lovingly grown flower.

But in the real business world, larger cultivators need to get product out the door. They don’t have one or two months to spend on curing.

That doesn’t mean, however, that cultivators must sacrifice quality for large-scale commercial production.

Read More

Louisiana closing in on expanded conditions list for medical cannabis program

Medical marijuana businesses would be permitted to sell MMJ to treat more diseases and disorders under two bills that are steps from final passage. Doctors could recommend medical cannabis for five conditions contained in House Bill 579, which Senators approved 25-9 on Wednesday: Glaucoma Severe muscle spasms Intractable pain Post-traumatic stress disorder Parkinson’s disease The Senate […]

Read More

Salt Lake district attorney supports Utah’s medical marijuana plan

The top prosecutor in Utah’s largest city is speaking out in support of an effort to legalize medical marijuana. Salt Lake County District Attorney Sim Gill said Tuesday that using medical cannabis should be a decision between a patient and a doctor rather than a criminal matter. The DA expressed his support for medical marijuana […]

Read More

Thanks to mayor, Alaska city OKs up to 25 retail marijuana stores

The number of retail cannabis shops in Fairbanks, Alaska, has been set at 25. After the City Council deadlocked 3-3 on whether to allow 15 or 25 stores, Fairbanks Mayor Jim Matherly was called in to break the tie, the Daily News-Miner reported. He voted to set the limit at 25, opting to give all entrepreneurs who […]

Read More

Lawsuit settled over fiery blast at Oregon marijuana extraction facility

The lawsuit filed by a construction worker who was badly burned after an explosion and fire at an Oregon marijuana extraction facility has been settled. Jacob Magley filed an $8.9 million suit in February 2017 against Jason Oei and William “Chris” West, who leased the Astoria building for growing marijuana and manufacturing butane hash oil, […]

Read More

Recreational marijuana use makes Michigan’s November ballot

A ballot drive to legalize recreational marijuana in Michigan has cleared a key hurdle. The state’s elections board said Thursday that organizers of a ballot drive to legalize adult use have collected enough signatures to qualify for the November ballot. According to Detroit TV station WDIV, the group seeking to get the issue on Michigan’s […]

Read More

NCIA leader vows to move forward while ex-board members question group’s direction

The National Cannabis Industry Association and its executive director, Aaron Smith, are at a crossroads. The coming months could prove pivotal.

To be sure, NCIA has racked up many successes along the way and can now boast of having its highest membership total ever.

It posted record revenue last year, and the number of cannabis businesses joining Denver-based NCIA continues to grow.

But critics of Smith and NCIA – including a growing number of veteran industry leaders – say the organization needs fresh leadership and a new direction.

Read More

FDA advisory panel gives thumbs-up to CBD epilepsy treatment

A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market. A panel of government health advisers gave a unanimous recommendation Thursday to the U.S. Food and Drug Administration to approve Epidiolex, a CBD medicine for rare epilepsy conditions that don’t respond to other drugs. The panel voted […]

Read More

Here’s how the FDA’s review of epilepsy drug could affect CBD companies

It’s shaping up to be a watershed summer for the cannabis industry with the U.S. Food and Drug Administration poised to approve the first drug made from the plant.

The agency’s impending decision on Epidiolex, an epilepsy treatment made of CBD extracted from cannabis flower, could upend decades of government insistence that the plant has no medicinal value.

Read More